Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of the Availability of Women's Health Clinics on Unwanted Pregnancy Among Active Duty Service Women.

Journal of women's health (2002)·2026
Same author

Perinatal Depression Among U.S. Active Duty Service Women.

Military medicine·2026
Same author

Prevalence of Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained Individuals.

JAMA dermatology·2026
Same author

Human leukocyte antigen alleles associated with inhibitor development in severe hemophilia A: analysis of the "My Life, Our Future" hemophilia A cohort.

Journal of thrombosis and haemostasis : JTH·2026
Same author

The efficacy and safety of benznidazole in adults with seropositive indeterminate form, Trypanosoma cruzi infection: a systematic review and meta-analysis.

BMC infectious diseases·2025
Same author

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer.

The Prostate·2025
Same journal

Correction: Luca et al. Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative Synthesis. <i>Diagnostics</i> 2026, <i>16</i>, 1224.

Diagnostics (Basel, Switzerland)·2026
Same journal

Association Between Systemic Inflammatory Response Biomarkers and Disease Activity in Systemic Lupus Erythematosus: A Multi-Center Retrospective Study.

Diagnostics (Basel, Switzerland)·2026
Same journal

Vertebrogenic Low Back Pain and Basivertebral Nerve Ablation: A Review of Mechanisms, Imaging-Driven Selection, and Clinical Outcomes.

Diagnostics (Basel, Switzerland)·2026
Same journal

Multivalvular Carcinoid Heart Disease: The Role of Echocardiography in Diagnosis and Selection for Heterotopic Bicaval Valve Implantation.

Diagnostics (Basel, Switzerland)·2026
Same journal

Data-Efficient and Explainable Multimodal Survival Prediction in NSCLC Using Deep Image Embeddings, Clinical Variables, and Gradient-Boosted Trees.

Diagnostics (Basel, Switzerland)·2026
Same journal

Anomalous Left Coronary Artery from the Pulmonary Artery: Cinematic Volume Rendering Technique for Enhanced Anatomic Visualization.

Diagnostics (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

485

Using Machine Learning to Create Prognostic Systems for Primary Prostate Cancer.

Kevin Guan1,2, Andy Guan1,3, Anwar E Ahmed1

  • 1F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD 20814, USA.

Diagnostics (Basel, Switzerland)
|October 16, 2025
PubMed
Summary
This summary is machine-generated.

A new machine learning model, EACCD, improves prostate cancer staging accuracy. It outperforms the current AJCC TNM system by better stratifying patients for personalized treatment.

Keywords:
C-indexEACCDcancer stagingdendrogrammachine learningprostate cancersurvival curves

More Related Videos

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.1K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Jan 15, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

485
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.1K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Oncology
  • Bioinformatics
  • Machine Learning

Background:

  • Cancer staging is crucial for treatment and prognosis.
  • The AJCC TNM 9th Version (2024) is the current standard for prostate cancer, using T, N, M, PSA, and Grade Group.
  • Refining prognostic systems can enhance outcome prediction and personalize treatment.

Purpose of the Study:

  • To develop and evaluate an improved prognostic framework for prostate cancer.
  • To compare the performance of a novel machine learning approach against the established AJCC staging system.

Main Methods:

  • Applied the unsupervised machine learning Ensemble Algorithm for Clustering Cancer Data (EACCD).
  • Developed EACCD models using five AJCC variables (T, N, M, P, G) and expanded to seven variables (including age and race).
  • Utilized prostate cancer patient data from the National Cancer Institute's SEER program.

Main Results:

  • EACCD effectively stratified patients into distinct prognostic groups with separated survival curves.
  • The seven-variable EACCD model achieved a C-index of 0.8504, outperforming the AJCC TNM system (C-index: 0.7676).
  • The EACCD approach demonstrated superior predictive accuracy compared to the current AJCC staging system.

Conclusions:

  • EACCD offers a more accurate prognostic framework for localized prostate cancer.
  • This machine learning model enhances risk stratification, supporting precision oncology.
  • Further validation in independent cohorts is recommended.